114 related articles for article (PubMed ID: 38811233)
1. A Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study.
Akao M; Tomita H; Nakai M; Kodani E; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Okamura T; Sasahara Y; Okumura K;
J Atheroscler Thromb; 2024 May; ():. PubMed ID: 38811233
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
JAMA Netw Open; 2020 Apr; 3(4):e202881. PubMed ID: 32293685
[TBL] [Abstract][Full Text] [Related]
3. A Novel Risk Stratification System for Ischemic Stroke in Japanese Patients With Non-Valvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
Circ J; 2021 Jul; 85(8):1254-1262. PubMed ID: 33762526
[TBL] [Abstract][Full Text] [Related]
4. Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF.
Kodani E; Tomita H; Nakai M; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y; Okumura K;
Eur Heart J Open; 2022 Nov; 2(6):oeac081. PubMed ID: 36583077
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Gao X; Cai X; Yang Y; Zhou Y; Zhu W
Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
[No Abstract] [Full Text] [Related]
6. Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.
Sakuma I; Uchiyama S; Atarashi H; Inoue H; Kitazono T; Yamashita T; Shimizu W; Ikeda T; Kamouchi M; Kaikita K; Fukuda K; Origasa H; Shimokawa H
Heart Vessels; 2019 Nov; 34(11):1839-1851. PubMed ID: 31127325
[TBL] [Abstract][Full Text] [Related]
7. Risk scores for major bleeding from direct oral anticoagulants: comparing predictive performance in patients with atrial fibrillation.
Campos-Staffico AM; Jacoby JP; Dorsch MP; Limdi NA; Barnes GD; Luzum JA
Res Pract Thromb Haemost; 2024 Jan; 8(1):102285. PubMed ID: 38292348
[TBL] [Abstract][Full Text] [Related]
8. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB
Am J Med; 2018 May; 131(5):574.e13-574.e27. PubMed ID: 29274754
[TBL] [Abstract][Full Text] [Related]
9. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
[TBL] [Abstract][Full Text] [Related]
10. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
11. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy--pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry.
Suzuki S; Yamashita T; Okumura K; Atarashi H; Akao M; Ogawa H; Inoue H
Circ J; 2015; 79(2):432-8. PubMed ID: 25501800
[TBL] [Abstract][Full Text] [Related]
12. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
13. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
Aggarwal R; Ruff CT; Virdone S; Perreault S; Kakkar AK; Palazzolo MG; Dorais M; Kayani G; Singer DE; Secemsky E; Piccini J; Tahir UA; Shen C; Yeh RW
Circulation; 2023 Sep; 148(12):936-946. PubMed ID: 37621213
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of CAS risk model and CHA
Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
[No Abstract] [Full Text] [Related]
16. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
Fox KAA; Virdone S; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Oto A; Misselwitz F; Piccini JP; Dalgaard F; Turpie AGG; Verheugt FWA; Kakkar AK;
Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):214-227. PubMed ID: 33892489
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the CHA
Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA
Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514
[TBL] [Abstract][Full Text] [Related]
18. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
Roldán V; Marín F; Fernández H; Manzano-Fernandez S; Gallego P; Valdés M; Vicente V; Lip GYH
Chest; 2013 Jan; 143(1):179-184. PubMed ID: 22722228
[TBL] [Abstract][Full Text] [Related]
20. Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry.
Yamashita T; Suzuki S; Inoue H; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A
Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):202-213. PubMed ID: 33822030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
